Filing excerpt
Capital expenditures were $121.0 and $126.0 for the three months ended March 31, 2026, and 2025, respectively.
sec.gov/Archives/edgar/data/920148/000092014826000139/lh-20260331.htmRead the full source
Labcorp10-Q: Capex increase
Company spent $121M in Q1 2026 capex on growth projects, facility expansion, and acquisition integration
What happened
Labcorp invested $121 million in capital expenditures during the first quarter of 2026.
Source
Other signals in this filing (6)
- Debt refinancingLabcorp secured a new $750M term loan in March 2026 for debt repayment and corporate useDebt refinancing
- Capex increaseLabcorp plans to spend up to $165M to acquire assets from Parkview Health System in 2026Capex increase
- Platform strategyLabcorp prioritizes acquisition integration as part of its $121M Q1 capital expenditurePlatform strategy
- Market expansionLabcorp invests $121M in Q1 CapEx, focusing on facility expansion and updatesMarket expansion
- Debt refinancingAmended its AR Facility, extending it to 2029 and allowing an increase to $825MDebt refinancing
- DivestitureLabcorp indicates focus on post-disposition efficiency, cutting related costs by $15.8MDivestiture
Extracted by Autobound
From the Signal API record- Signal
- 10-Q: Capex increase
What this signalsFilings often name leadership changes, deals and spending plans.
- Fiscal year end
- 03/31
- Filed
- May 4, 2026
More from Labcorp
- PatentsLaboratory Corporation of America Holdings's patent output is accelerating: 17 grants in the past year, 2 in the past 30 days.Patents
- 8-KLabcorp faces 'steep annual payment cuts' from new CMS reimbursement rates for 2027-20298-K
- RevenueLabcorp Unveils Long-Term Outlook Driven by Specialty TestingRevenue
- AcquisitionLabcorp acquires MLM Medical Labs in global expansionAcquisition
- X (Twitter)Labcorp acquired MLM Medical Labs, expanding its wholly-owned laboratory network across four continents.X (Twitter)
- LaunchLabcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial ComplexityLaunch
More 10-Q signals at other companies
- SEC 10-QMillerKnoll, Inc.Jeffrey M. Stutz appointed Interim Chief Executive Officer.SEC 10-Q
- SEC 10-QCID HoldCo, Inc.Disclosed material weaknesses in financial reporting due to insufficient accounting staff and controls.SEC 10-Q
- SEC 10-QScholastic CorporationCore school channels decline with fewer book fairs and lower club participation.SEC 10-Q
The full record
From the Signal API recordNumbers
- Dollar figure
- $121M (Q1 2026 Capital Expenditures)
- Percent
- 3.4% (Capital expenditures as a percentage of revenues)
Details
- CIK
- 920148
- Accession number
- 0000920148-26-000139
- Timeframe
- Current quarter
- Filing year
- 2026
- Fiscal year
- 0
- Why it matters
- Budget available
- Signal category
- Financial
Extraction
- Confidence
- High
- Relevance
- 80%
- Sentiment
- Positive
- Detected
- May 5, 2026
- signal_type
sec-10q- signal_subtype
capexIncrease
Use this data
Get every 10-Q signal for Labcorp and the companies you sell to, in the tools you already use.
Ask Claude about it
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Labcorp this week?”
Send it to your own tools
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Try it free
Sign up and spend your free credits on the companies you sell to.
Start Free1,000 free credits
The API returns more than this page shows
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the API
Signal
signal_nameValue in the APIassociationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONHide the full JSONThe record on this page and the API request
GET /v1/signals/ae919e17-7bd9-4480-8755-f3154b008ffe returns this record as JSON. POST /v1/companies/enrich returns every signal for labcorp.com.
{
"signal_id": "ae919e17-7bd9-4480-8755-f3154b008ffe",
"signal_type": "sec-10q",
"signal_subtype": "capexIncrease",
"detected_at": "2026-05-05T08:48:21.282+00:00",
"company": {
"name": "Labcorp",
"domain": "labcorp.com"
},
"data": {
"detail": "Labcorp invested $121 million in capital expenditures during the first quarter of 2026. These funds are earmarked for supporting core business growth, expanding and updating facilities, and integrating recent acquisitions, creating opportunities for vendors in construction, IT infrastructure, and operational systems.",
"metrics": {
"pct": 0.034,
"timeframe": "current_quarter",
"pct_context": "Capital expenditures as a percentage of revenues",
"dollar_context": "Q1 2026 Capital Expenditures",
"dollar_millions": 121
},
"summary": "Company spent $121M in Q1 2026 capex on growth projects, facility expansion, and acquisition integration",
"excerpts": "Capital expenditures were $121.0 and $126.0 for the three months ended March 31, 2026, and 2025, respectively.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/920148/000092014826000139/lh-20260331.htm",
"filing_date": "2026-05-04",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "03/31",
"sales_relevance": "Budget available",
"signal_category": "financial"
}
}
curl https://signals.autobound.ai/v1/signals/ae919e17-7bd9-4480-8755-f3154b008ffe \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"labcorp.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.